EE48 Cost-Effectiveness of Alternative Diagnostic Testing Pathways with Whole Exome Sequencing (WES) in a Rare Disease Patient Population: The Canadian Care-for-Rare SOLVE (SOLVE) Multi-Centre Observational Cohort
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.302
https://www.valueinhealthjournal.com/article/S1098-3015(22)00503-4/fulltext
Title :
EE48 Cost-Effectiveness of Alternative Diagnostic Testing Pathways with Whole Exome Sequencing (WES) in a Rare Disease Patient Population: The Canadian Care-for-Rare SOLVE (SOLVE) Multi-Centre Observational Cohort
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00503-4&doi=10.1016/j.jval.2022.04.302
First page :
Section Title :
Open access? :
No
Section Order :
10263